Safety and immunogenicity of the RIVM hexavalent meningococcal B vesicle vaccine for Rotterdam children aged 2-3 and 7-8
Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles
Age-related immunity to meningococcal serogroup C vaccination: an increase in the persistence of IgG2 correlated with a decrease in the avidity of IgG